These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17077469)

  • 1. [Impaired immunological status due to the urogenital chlamydiosis in women of reproductive age and its correction].
    Tabukashvili NG
    Georgian Med News; 2006 Oct; (139):57-60. PubMed ID: 17077469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of disorders in interferon status of patients with urogenital chlamydial infection].
    Abidov AM; Saĭitkulov AM
    Lik Sprava; 2003; (3-4):81-4. PubMed ID: 12889367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytokines and smoking in the cases of reactive arthritis during urogenital chlamydiosis].
    Kiknadze NG; Bukiia TSh; Kartvelishvili EIu
    Georgian Med News; 2006 May; (134):76-80. PubMed ID: 16783072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factors of urogenital chlamydiosis in women of reproductive age].
    Arustamian KK
    Georgian Med News; 2006 Oct; (139):76-8. PubMed ID: 17077475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimization of urogenital chlamydiosis diagnosis in reproductive age women].
    Arustamian KK; Dzhinanian KO; Aĭrapetian MG
    Georgian Med News; 2006 Nov; (140):33-5. PubMed ID: 17179584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The basic properties of the causative agent of chlamydiosis and its role in the development of urogenital tract infections].
    Burova AA; Abdullaeva SA; Torganova EN
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):107-11. PubMed ID: 10852074
    [No Abstract]   [Full Text] [Related]  

  • 7. [The anti-infective resistance system in women with chronic urogenital inflammatory diseases of chlamydia ethiology].
    Savitskaia KI; Vorob'ev AA; Zur NV
    Vestn Ross Akad Med Nauk; 2006; (6):18-22. PubMed ID: 16869255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring of microbiological and immunological disorders in urogenital chlamydiosis in people of reproductive age.].
    Omarova SM; Akhmedova RS; Bagandova DS; Akayeva FS; Muslimov MO; Isayeva RI
    Klin Lab Diagn; 2019; 64(1):46-48. PubMed ID: 30912884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The combined therapy of patients with gonorrheal-chlamydial urogenital infections by leukinferon immunocorrection].
    Kuznetsov VP; Dubenskiĭ VV; Delektorskiĭ VV; Igoshin IuM; Beliaev DL; Iashkova GN; Babaiants AA
    Ter Arkh; 1993; 65(11):39-42. PubMed ID: 8108795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune status during fracture of lower jaw.
    Kublashvili M; Menabde G; Korsantia B; Apridonidze K
    Georgian Med News; 2006 Feb; (131):101-4. PubMed ID: 16575147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Where do the immunostimulatory effects of oral proteolytic enzymes ('systemic enzyme therapy') come from? Microbial proteolysis as a possible starting point.
    Biziulevicius GA
    Med Hypotheses; 2006; 67(6):1386-8. PubMed ID: 16870353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
    Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
    J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe herpetic infection].
    Didkovskiĭ NA; Malashnkova IK; Tanasova AN; Zuĭkov IA; Khitrik NM; Sarsaniia ZhSh
    Ter Arkh; 2007; 79(11):52-7. PubMed ID: 18219975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cellular immunity in patients with urogenital chlamydiosis].
    Mikolauskas VP
    Klin Lab Diagn; 2004 Apr; (4):36-8. PubMed ID: 15188743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Wobenzym in the combined pathogenetic therapy of chronic urethrogenic prostatitis].
    Martynenko AV
    Lik Sprava; 1998 Aug; (6):118-20. PubMed ID: 9844894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
    Hickey DK; Aldwell FE; Beagley KW
    Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enzyme therapy of patients with pyo-inflammatory disease of maxillofacial area].
    Minaev SV; Ibragimov OR; Zelenskiĭ VA; Minaeva NV
    Voen Med Zh; 2007 Nov; 328(11):25-7, 96. PubMed ID: 18306709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin treatment modulates cytokine production in Chlamydia trachomatis infected women.
    Srivastava P; Jha HC; Salhan S; Mittal A
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):478-82. PubMed ID: 19389045
    [No Abstract]   [Full Text] [Related]  

  • 20. [Composition of microflora and antibiotic sensitivity of bacteria of the women urogenital tract].
    Skliar TV; Krysenko AV; Sirokvasha EA; Vinnikov AI
    Mikrobiol Z; 2007; 69(3):50-7. PubMed ID: 17682531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.